Home / Market News / $HUM
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

Barclays Raises Price Target on Humana to $587

Nov 9, 2026, 7:07 PM UTC · Primary ticker $HUM

Barclays has increased its price target for Humana to $587 from $582, while maintaining an 'Overweight' rating. This modest price target adjustment suggests a positive, but not dramatically altered, outlook for Humana's stock performance, implying a potential upside of 35.3%.

Barclays updated its outlook on Humana, raising its price target by a modest 0.9% to $587 while reiterating an 'Overweight' rating. This adjustment signals continued confidence from Barclays in Humana's future performance, implying a significant potential upside of 35.3% from its recent closing price. For traders, this indicates a positive sentiment from a major investment bank, which could provide some upward momentum for HUM in the short term. However, the small magnitude of the price target increase suggests this is not a major re-rating event, but rather a fine-tuning of existing positive sentiment. The key opportunity for traders lies in the implied upside, but the risk is that the market may have already priced in much of this positive outlook.

$HUM positive Price target increase and maintained 'Overweight' rating
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.